Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer
- 1 September 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (17) , 4191-4196
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81373280, 21502121)
- Project Funded by China Post Doctoral Science Foundation (2015M570258)
- General Scientific Research Projects of Department of Education in Liaoning Province (L2014382)
- Guangxi Normal University
- Ministry of Education of China (CMEMR2015-B07)
- Shenyang Pharmaceutical University
This publication has 32 references indexed in Scilit:
- Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide DonorJournal of Medicinal Chemistry, 2015
- Novel Hybrids of (Phenylsulfonyl)furoxan and Anilinopyrimidine as Potent and Selective Epidermal Growth Factor Receptor Inhibitors for Intervention of Non-Small-Cell Lung CancerJournal of Medicinal Chemistry, 2013
- Nitric oxide release: Part II. Therapeutic applicationsChemical Society Reviews, 2012
- S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal InjuryScience, 2009
- Nitric Oxide: Cancer Target or Anticancer Agent?Current Cancer Drug Targets, 2009
- Nitric oxide, Nω-hydroxy-l-arginine and breast cancerNitric Oxide, 2008
- Nitric Oxide Donors: Chemical Activities and Biological ApplicationsChemical Reviews, 2002
- Specific Coupling of NMDA Receptor Activation to Nitric Oxide Neurotoxicity by PSD-95 ProteinScience, 1999
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proceedings of the National Academy of Sciences of the United States of America, 1987